Our data have also showed associations of the CNR2 gene with depression, drug abuse, anorexia nervosa and schizophrenia in a human population and also in the CMS model of depression [17,  45] suggesting that the CB2-Rs may be involved in the endocannabinoid signaling mechanisms associated with the regulation of emotionality beyond immune function. Here, CNR2 is linked to depressive symptom measurement.